
|Articles|January 1, 2005
Endorectal MRI: When to consider in PCa detection
MRI/MRSI is best suited for patients with newly diagnosed prostate cancer who are at high risk of extracapsular extent and who are considering various forms of local therapy.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study suggests potential diuretic effect with nadofaragene firadenovec
2
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
3
Published data show DFS benefit with aglatimagene besadenovec in localized prostate cancer
4
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
5











